Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus

Citation
Y. Hishikawa et al., Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus, BR J CANC, 81(4), 1999, pp. 712-720
Citations number
49
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
81
Issue
4
Year of publication
1999
Pages
712 - 720
Database
ISI
SICI code
0007-0920(199910)81:4<712:MECWMA>2.0.ZU;2-W
Abstract
The goal of this study is to clarify whether the expression of metallothion ein (MT) could affect the prognosis and the metastatic potential of squamou s cell carcinoma (SCC) of the oesophagus. In paraffin-embedded specimens re sected from 57 patients, MT mRNA and protein expressions were detected by i n situ hybridization and immunohistochemistry respectively. The expression of MT was evaluated in respect of clinicopathologic variables and patients' survival. MT mRNA expression was significantly associated with the proport ion of lymph node metastasis (71% in MT mRNA-positive tumours vs 42% in MT mRNA-negative tumours; P = 0.0343) and that of distant metastasis (29% in M T mRNA-positive tumours vs 5% in MT mRNA-negative tumours; P = 0.0452), In respect of MT protein expression, the frequency of distant metastasis was m ore common in MT-positive tumours than in MT-negative tumours (30% in MT-po sitive tumours vs 8% in MT-negative tumours; P = 0.0446). The survival rate of the patients with MT protein-negative tumours was significantly better than that of the patients with MT protein-positive tumours (P = 0.0340). Th ere was a positive correlation between the expression of MT protein and tha t of proliferating cell nuclear antigen (P = 0.0018). Therefore, we conclud e that MT expression, both at the mRNA and protein levels, may be a potenti al marker predicting metastatic and proliferative activities of oesophageal SCC. (C) 1999 Cancer Research Campaign.